Terug
Dagbereik
€ 18,61
€ 19,22
52-Weeksbereik
€ 10,01
€ 24,33
Volume
187.677
50D / 200D Gem.
€ 20,20
/
€ 16,40
Vorige Slotkoers
€ 18,50
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -13,4 | 0,4 |
| P/B | 4,6 | 2,9 |
| ROE % | -30,8 | 3,7 |
| Net Margin % | -60,0 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -41,58M
PEG of 0,26 suggests growth is underpriced
Capital efficient — spends only 0,86% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)36,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-30,83%
ROIC-24,66%
Net Margin-59,97%
Op. Margin-65,57%
Veiligheid
Debt / Equity
0,14
Current Ratio9,73
Interest Coverage-30,90
Waardering
P/E Ratio
-13,39
P/B Ratio4,60
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,09% | Revenue Growth (3Y) | 40,33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 89,06M | Net Income (TTM) | -53,41M |
| ROE | -30,83% | ROA | -27,28% |
| Gross Margin | 87,89% | Operating Margin | -65,57% |
| Net Margin | -59,97% | Free Cash Flow (TTM) | -41,58M |
| ROIC | -24,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 9,73 |
| Interest Coverage | -30,90 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -13,39 | P/B Ratio | 4,60 |
| P/S Ratio | 8,03 | PEG Ratio | 0,26 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 715,18M | Enterprise Value | 696,98M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 89,06M | 65,44M | 45,23M | 25,92M |
| Net Income | -53,41M | -40,46M | -29,46M | -37,16M |
| EPS (Diluted) | -1,46 | -3,39 | -1,26 | -1,59 |
| Gross Profit | 78,27M | 56,75M | 38,16M | 21,49M |
| Operating Income | -58,40M | -39,71M | -30,04M | -36,02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 195,80M | 225,41M | 58,92M | 86,46M |
| Total Liabilities | 40,47M | 34,25M | 171,17M | 172,86M |
| Shareholders' Equity | 155,34M | 191,17M | -112,25M | -86,40M |
| Total Debt | 22,28M | 21,96M | 14,20M | 18,22M |
| Cash & Equivalents | 40,48M | 194,37M | 34,50M | 68,24M |
| Current Assets | 186,72M | 217,27M | 51,96M | 79,80M |
| Current Liabilities | 19,19M | 12,99M | 21,60M | 9,86M |